Jay Fine
6Patents
3h-index
31Co-inventors
57Inventor score
Filing activity: Mar 24, 1995 → Jul 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7132445B2 | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | Chemistry; Metallurgy | 36 | Expired |
| US5866134A | Method for enhancing the antibody response to specific antigens with Interleukin-10 | Human Necessities | 23 | Expired |
| US7560449B2 | Methods and therapeutic combinations for the treatment of demyelination | Human Necessities | 4 | Expired |
| US7960433B2 | Treatment of chemokine mediated diseases | Human Necessities | 3 | Active |
| US5939431A | Naphthyridines which affect IL-4 and G-CSF | Chemistry; Metallurgy | 1 | Expired |
| US12098207B2 | Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.